| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94b1bff882d9cf015fb59a510db36d1b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2012-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48ad5a58cbeebbb90b06a86c7f534e82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ca1c1d2d3243a5ec71102f05e008c79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7201b0dc385af3952a5b4b74041b7cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee5d82ea940da64b951c51d340977c66 |
| publicationDate |
2013-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130136012-A |
| titleOfInvention |
Cancer diagnostic method and diagnostic kit using NK cell activity measurement |
| abstract |
The present invention relates to a cancer diagnosis method and a diagnostic kit through the measurement of the activity of NK cells. According to the present invention, it is possible to diagnose whether or not cancer is generated by measuring the activity of NK cells in the blood by the change of the immune system occurring in the body when cancer is generated. The present invention makes it possible to easily predict whether or not cancer is generated by using the blood of a test subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190022395-A |
| priorityDate |
2011-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |